Related Experiment Video
Updated: May 31, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
CX3CR1 as a target for airways inflammation
1Queensland University of Technology, Discipline of Medical Sciences, Brisbane, Australia. sheila.doggrell@qut.edu.au
Expert Opinion on Therapeutic Targets
|July 1, 2011
Summary
Targeting CX3CR1 shows promise for reducing asthma symptoms. Further research is needed to compare CX3CR1 inhibitors with glucocorticoids for treating airway inflammation.
Area of Science:
- Immunology
- Pulmonary Medicine
- Cell Biology
Background:
- Asthma involves significant inflammation.
- Chemokine CX3CL1 is upregulated in asthma patients' airways.
- CX3CR1, the receptor for CX3CL1, is implicated in airway inflammation.
Discussion:
- A mouse model demonstrated that inhibiting CX3CR1 reduced asthma.
- This suggests CX3CR1 antagonists could be a novel asthma therapy.
- Glucocorticoids are known to modulate the CX3CL1-CX3CR1 pathway.
Key Insights:
- CX3CR1 inhibition effectively reduced asthma in a preclinical model.
- The CX3CL1-CX3CR1 pathway is a potential therapeutic target for asthma.
- Further studies are warranted to explore CX3CR1 inhibitors' efficacy.
Outlook:
- Investigate if CX3CR1 inhibitors offer advantages over glucocorticoids for airway inflammation.
- Evaluate the potential of developing CX3CR1 as a human therapeutic target for asthma.
- Conduct comparative studies in animal models to assess treatment efficacy.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...